GlassScriptPhysician profile
Alberto Guillermo Corica
NPI 1194927376
$4,993.60
in general payments reported to CMS, 2019-2025
24 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,536 · 2020: $166 · 2021: $861 · 2022: $1,412 · 2023: $672 · 2024: $196 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,150.58 | 2019-2020 | |
| Procept Biorobotics Corporation | $626.70 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $488.60 | 2019-2023 | Xtandi |
| Pfizer INC. | $458.94 | 2019-2024 | |
| Teleflex LLC | $423.99 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $267.11 | 2019-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $238.73 | 2019-2023 | |
| Boston Scientific Corporation | $213.31 | 2019-2025 | Tria Firm, Spaceoar Vue System - 10ml |
| Endo Pharmaceuticals INC. | $171.63 | 2020-2023 | Aveed, Xiaflex |
| Myovant Sciences INC. | $163.12 | 2021-2022 | |
| Coloplast Corp | $155.70 | 2021-2023 | Titan, Porges Coloplast |
| Olympus Latin America, INC. | $130.00 | 2024 | Soltive |
| Sumitomo Pharma America, INC. | $98.15 | 2023-2025 | Orgovyx |
| Blue Earth Diagnostics | $90.07 | 2021-2025 | Posluma |
| Palette Life Sciences, INC. | $50.31 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $47.26 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $43.93 | 2023 | Prolaris |
| Hollister Incorporated | $36.58 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $33.52 | 2023 | Seglentis |
| Amgen INC. | $32.40 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $18.66 | 2022 | |
| Convatec INC. | $18.44 | 2021 | |
| Urovant Sciences INC | $18.23 | 2021 | |
| Urogen Pharma, INC. | $17.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Corica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.